Microbial production of conjugated linoleic acid and conjugated linolenic acid relies on a multienzymatic system

• Published in: Microbiology and molecular biology reviews 2018-12, Vol.82 (4), p.1
• Main Authors: Salsinha, Ana Sofia, Pimentel, Lígia, Fontes, Ana Luiza, Gomes, Ana Maria, Rodríguez-Alcalá, Luis Miguel
• Format: Article
• Language: English
• Subjects: Animals; Bacteria; Bacterial Proteins - genetics; Bacterial Proteins - metabolism; Bifidobacterium - enzymology; Bifidobacterium - genetics; Cellular stress response; Energy metabolism; Enzymes; Fatty acids; Gene sequencing; Genes; Genetic screening; Genetic transformation; Homology; Humans; Intestinal microflora; Isomerases - genetics; Isomerases - metabolism; Isomers; Lactobacillus - enzymology; Lactobacillus - genetics; Linoleate isomerase; Linoleic acid; Linoleic Acids, Conjugated - biosynthesis; Linolenic acid; Linolenic Acids - biosynthesis; Lipid metabolism; Lipid Metabolism - physiology; Lipids; Metabolism; Microbiota; Microorganisms; Myosin; Propionibacterium - enzymology; Propionibacterium - genetics; Proteins; Rats; Rats, Wistar; Review; Screening
• ISSN: 1092-2172; 1098-5557
• DOI: 10.1128/MMBR.00019-18

Conjugated linoleic acids (CLAs) and conjugated linolenic acids (CLNAs) have gained significant attention due to their anticarcinogenic and lipid/energy metabolism-modulatory effects. However, their concentration in foodstuffs is insufficient for any therapeutic application to be implemented. From a biotechnological standpoint, microbial production of these conjugated fatty acids (CFAs) has been explored as an alternative, and strains of the genera Propionibacterium, Lactobacillus, and Bifidobacterium have shown promising producing capacities. Current screening research works are generally based on direct analytical determination of production capacity (e.g., trial and error), representing an important bottleneck in these studies. This review aims to summarize the available information regarding identified genes and proteins involved in CLA/CLNA production by these groups of bacteria and, consequently, the possible enzymatic reactions behind such metabolic processes. Linoleate isomerase (LAI) was the first enzyme to be described to be involved in the microbiological transformation of linoleic acids (LAs) and linolenic acids (LNAs) into CFA isomers. Thus, the availability of lai gene sequences has allowed the development of genetic screening tools. Nevertheless, several studies have reported that LAIs have significant homology with myosin-cross-reactive antigen (MCRA) proteins, which are involved in the synthesis of hydroxy fatty acids, as shown by hydratase activity. Furthermore, it has been suggested that CLA and/or CLNA production results from a stress response performed by the activation of more than one gene in a multiple-step reaction. Studies on CFA biochemical pathways are essential to understand and characterize the metabolic mechanism behind this process, unraveling all the gene products that may be involved. As some of these bacteria have shown modulation of lipid metabolism in vivo, further research to be focused on this topic may help us to understand the role of the gut microbiota in human health.